Wishbone Biotech

📍 Flémalle-Grande, Belgium🗓 Founded 2013👥 11 employees💰 Last funded Apr 2014
Our goal is to revolutionize bone regeneration for dental implants by developing superior bone graft substitute products with breakthrough technology and innovative procedure. The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone. Wishbone biomaterials result from the collaboration between chemists, biomedical engineers and clinician experts in dental tissue engineering. Wishbone has invested in a high tech facility for R&D, production and QC, including a qualified ISO 7 cleanroom. The company is ISO 13485 certified.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Wishbone Biotech?
Wishbone Biotech has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Wishbone Biotech last raise funding?
The most recent investment in Wishbone Biotech recorded on gritt.io was in April 2014.
When was Wishbone Biotech founded?
Wishbone Biotech was founded in 2013.
What industry is Wishbone Biotech in?
Wishbone Biotech operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Wishbone Biotech based?
Wishbone Biotech is headquartered in Flémalle-Grande, Belgium.